Haibo Wang
Corporate Officer/Principal bei HARPOON THERAPEUTICS, INC.
Profil
Haibo Wang is a professional who currently holds the position of Senior Vice President-Business Development at Harpoon Therapeutics, Inc. He previously worked as Vice President-Business Development at Hummingbird Bioscience Pte Ltd.
Wang holds an MBA from Duke University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Tsinghua University.
Aktive Positionen von Haibo Wang
Unternehmen | Position | Beginn |
---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2023 |
Ehemalige bekannte Positionen von Haibo Wang
Unternehmen | Position | Ende |
---|---|---|
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Corporate Officer/Principal | - |
Ausbildung von Haibo Wang
Duke University | Masters Business Admin |
The Johns Hopkins University | Graduate Degree |
Tsinghua University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HARPOON THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Commercial Services |